Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy

Cardiac Arrest or DeathTherapy and Intervention

Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

J Am Coll Cardiol.

Batzner A, Pfeiffer B, Neugebauer A, Aicha D, Blank C, Seggewiss H

doi: 10.1016/j.jacc.2018.09.064.

Long-term mortality in patients with atrial septal defect: a nationwide cohort-study

Eur Heart J.

Nyboe C, Karunanithi Z, Nielsen-Kudsk JE, Hjortdal VE

doi: 10.1093/eurheartj/ehx687.

Heart Failure

Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities

Eur J Heart Fail.

Moulig V, Pfeffer TJ, Ricke-Hoch M, Schlothauer S, Koenig T, Schwab J, Berliner D, Pfister R, Michels G, Haghikia A, Falk CS, Duncker D, Veltmann C, Hilfiker-Kleiner D, Bauersachs J

doi: 10.1002/ejhf.1624.

Cardiac Arrest or DeathHeart, Artery and Coronary Diseases

Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients

J Am Heart Assoc.

Adler A, Fourey D, Weissler-Snir A, Hindieh W, Chan RH, Gollob MH, Rakowski H

doi: 10.1161/JAHA.116.005152.

RECOMMENDED

HypertensionLipid-Lowering DrugsThrombosis and Stroke

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial

Lancet.

Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P

doi: 10.1016/S0140-

Heart, Artery and Coronary Diseases

Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy

JAMA Cardiol.

Fumagalli C, Maurizi N, Day SM, Ashley EA, Michels M, Colan SD, Jacoby D, Marchionni N, Vincent-Tompkins J, Ho CY, Olivotto I, SHARE Investigators.

doi: 10.1001/jamacardio.2019.4268.

Heart, Artery and Coronary Diseases

D-dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events and Cancer in Stable Coronary Heart Disease Patients: The LIPID Study

Circulation.

Simes J, Robledo KP, White HD, Espinoza D, Stewart RA, Sullivan DR, Zeller T, Hague W, Nestel PJ, Glasziou PP, Keech AC, Elliott J, Blankenberg S, Tonkin AM; LIPID study investigators

doi: 10.1161/CIRCULATIONAHA.

Heart FailureTherapy and Intervention

Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

JACC Cardiovasc Interv.

Chamandi C, Barbanti M, Munoz-Garcia A, Latib A, Nombela-Franco L, Gutiérrez-Ibanez E, Veiga-Fernandez G, Cheema AN, Cruz-Gonzalez I, Serra V, Tamburino C, Mangieri A, Colombo A, Jiménez-Quevedo P, Elizaga J, Laughlin G, Lee DH, Garcia Del Blanco B, Rodriguez-Gabella T, Marsal JR, Côté M, Philippon F, Rodés-Cabau J

doi: 10.1016/j.jcin.2017.10.032.

Heart, Artery and Coronary Diseases

Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population

JAMA Cardiol.

Lorenzini M, Anastasiou Z, O'Mahony C, Guttman OP, Gimeno JR, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Garcia-Pavia P, Limongelli G, Pavlou M, Elliott PM, Hypertrophic Cardiomyopathy Outcomes investigators.

doi: 10.1001/jamacardio.2019.4534.

Related content

Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Long-term mortality in patients with atrial septal defect: a nationwide cohort-study

Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities

Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial

Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy

D-dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events and Cancer in Stable Coronary Heart Disease Patients: The LIPID Study

Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population